Study of SiRNA-loaded PS-mPEG/CaP nanospheres on lung cancer
Source abstract
Abstract
An ultrasound-adsorption method was used to prepare Bcl-2-SiRNA-loaded PS-mPEG/CaP nanospheres. The size and zeta potential were 18.41 ± 4.31 nm (n = 5) and −23.5 ± 0.6 mV, respectively. The entrapment efficiency of SiRNA was 92.86 %. MTT assay results confirmed that the blank nanospheres demonstrated a negligible cytotoxicity response in H1299 cells. Flow cytometer analysis results demonstrated that PS-mPEG/CaP NSs could carry SiRNA into the cells effectively. RT-PCR experiments and apoptosis assay results approved that, compared with free SiRNA, SiRNA-loaded PS-mPEG/CaP NSs could silence Bcl-2 gene and induce cell apoptosis effectively. In vivo distribution results confirmed PS-mPEG/CaP NSs could carry SiRNA enter the tumor tissue effectively. Taken together, these results suggest that the Bcl-2-SiRNA-loaded PS-mPEG/CaP nanospheres have great potential to be used to cure lung cancer.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Cell death mechanisms and regulation · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (25)
Show source-provided references
1. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281:1322–132610.1126/science.281.5381.1322 ↗
2. Bradley G, Juranka PF, Ling V (1998) Mechanism of multidrug resistance. Biochim Biophys Acta 948:87–128
3. Chawla-Sarkar M, Lindner DJ (2003) Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8:237–24910.1023/A:1023668705040 ↗
4. Choi SY, Jang SH, Park J, Jeong S, Park JH, Ock KS, Lee K, Yang SI, Joo SW, Ryu PD, Lee SY (2012) Cellular uptake and cytotoxicity of positively charged chitosan gold nanoparticles in human lung adenocarcinoma cells. J Nanopart Res 14:123410.1007/s11051-012-1234-5 ↗
5. David FC, Amy EB, Stephen R (1995) Reliability and validity of the functional assessment of cancer therapy-lung (FACT-L) quality of life instrument. Lung Cancer 12:199–22010.1016/0169-5002(95)00450-F ↗
6. Dorsett Y, Tuschl T (2004) siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3:318–32910.1038/nrd1345 ↗
7. Dykxhoorn DM, Lieberman J (2005) The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med 56:401–42310.1146/annurev.med.56.082103.104606 ↗
8. Karimi M, Avci P, Mobasseri R, Hamblin MR, Naderi MH (2013) The novel albumin–chitosan core–shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation. J Nanopart Res 15:165110.1007/s11051-013-1651-0 ↗
9. Kester M, Heakal Y, Fox T (2008) Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett 8:4116–412110.1021/nl802098g ↗
10. Liu M, Gu XH, Zhang K, Ding Y, Wei XB, Zhang XM, Zhao YX (2013) Gold nanoparticles trigger apoptosis and necrosis in lung cancer cells with low intracellular glutathione. J Nanopart Res 15:174510.1007/s11051-013-1745-8 ↗
11. Lowe SW, Lin AW (2000) Apotosis in cancer. Carcinogenesis 21:485–49510.1093/carcin/21.3.485 ↗
12. Nicholson DW, Thomberry NA (2003) Apoptosis: life and death decisions. Science 299:214–21510.1126/science.1081274 ↗
13. Novina CD, Sharp PA (2004) The RNAi revolution. Nature 430:161–16410.1038/430161a ↗
14. Ryther RC, Flynt AS, Phillips JA, Patton JG (2005) siRNA therapeutics: big potential from small RNAs. Gene Ther 12:5–1110.1038/sj.gt.3302356 ↗
15. Singh S, Bhardwaj P, Singh V (2008) Synthesis of nanocrystalline calcium phosphate in microemulsion—effect of nature of surfactants. J Colloid Interface Sci 319:322–32910.1016/j.jcis.2007.09.059 ↗
16. Tang HL, Xie XH, Guo JL, Wei WD, Wu MQ, Liu P, Kong Y, Yang L, Hung MC, Xie XM (2013) Efficient systemic DNA delivery to the tumor by self-assembled nanoparticle. J Nanopart Res 16:221310.1007/s11051-013-2213-1 ↗
17. Tsamandas AC, Kardamakis D, Tsiamalos P (2009) The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome. Anticancer Res 29:703–709
18. Veis D, Sorenson S, Shutter J (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, olycystic kidney, and hypopigmented hair. Cell 75:229–24010.1016/0092-8674(93)80065-M ↗
19. Venkatasubbu GD, Ramasamy S, Avadhani GS, Palanikumar L, Kumar J (2012) Size-mediated cytotoxicity of nanocrystalline titanium dioxide, pure and zinc-doped hydroxyapatite nanoparticles in human hepatoma cells. J Nanopart Res 14:81910.1007/s11051-012-0819-3 ↗
20. Wang Q, Liu PF, Sun Y, Wu H, Li XY, Zhang ZR, Duan YR (2013a) Pluronic-poly[-(4-aminobutyl)-l-glycolic acid] polymeric micelle-like nanoparticles as carrier for drug delivery. J Nanosci Nanotechnol 13:1–810.1039/9781849736817-00001 ↗
21. Wang CH, Li XH, Wang Y, Liu Z, Fu L, Hu LK (2013b) Enhancement of radiation effect and increase of apoptosis in lung cancer cells by thio-glucose-bound gold nanoparticles at megavoltage radiation energies. J Nanopart Res 15:164210.1007/s11051-013-1642-1 ↗
22. Wang Q, Liu P, Liu PF, Gong T, Li SM, Duan YR, Zhang ZR (2014a) Preparation, blood coagulation and cell compatibility evaluation of chitosan-graft-polylactide copolymers. Biomed Mater. doi: 10.1088/1748-6041/9/1/015007
23. Wang Q, Gong T, Sun X, Zhang ZR (2014b) Uptake mechanism and endosomal fate of drug-phospholipid lipid nanoparticles in subcutaneous and in situ hepatoma. J Biomed Nanotechnol 10:993–100310.1166/jbn.2014.1776 ↗
24. Wang Q, Liu PF, Sun Y, He ZL, Gong T, Sun X, Zhang ZR, Duan YR (2014c) Preparation and properties of biocompatible PS-PEG/calcium phosphate nanospheres. Nanotoxicology. doi: 10.3109/17435390.2014.91138110.3109/17435390.2014.911381 ↗
25. Yellepeddi VK, Vangara KK, Palakurthi S (2013) Poly(amido)amine (PAMAM) dendrimer–cisplatin complexes for chemotherapy of cisplatin-resistant ovarian cancer cells. J Nanopart Res 15:189710.1007/s11051-013-1897-6 ↗